ScholarIQanswers from OpenAlex
Therapeutic Advances in Respiratory Disease
JournalCitation impact & published research
Therapeutic Advances in Respiratory Disease is a journal indexed in ScholarIQ from OpenAlex.
What is the OpenAlex record for Therapeutic Advances in Respiratory Disease?
ScholarIQopenalex
The OpenAlex for Therapeutic Advances in Respiratory Disease is on the source record.
What are the most-cited papers on Therapeutic Advances in Respiratory Disease?
ScholarIQmost cited works
Clinical characteristics and risk factors for severity of COVID-19 outside Wuhan: a double-center retrospective cohort study of 213 cases in Hunan, China
Xingsheng Hu, Chunhong Hu, Yong Yang, Juan Chen, Ping Zhong, Yajing Wen, Xiangyu Chen
Impact of adherence to treatment with inhaled corticosteroids/long-acting β-agonists on asthma outcomes in the United States
Carlyne M. Averell, François Laliberté, Guillaume Germain, Mei Sheng Duh, Matthew D. Rousculp, Sean D. MacKnight, David Slade
LABA/LAMA fixed-dose combinations <i>versus</i> LAMA monotherapy in the prevention of COPD exacerbations: a systematic review and meta-analysis
Ching-Yi Chen, Wang-Chun Chen, Chi‐Hsien Huang, Yi-Ping Hsiang, Chau‐Chyun Sheu, Yung‐Che Chen, Meng-Chih Lin, Kuo-An Chu, Cheng-Hung Lee, Yu‐Feng Wei
Real-world outcomes in patients with chronic obstructive pulmonary disease initiating long-acting mono bronchodilator therapy
Lindsay G.S. Bengtson, Michael DePietro, Jeffrey McPheeters, Kathleen M. Fox
Dynamics of interstitial lung disease following immunosuppressive treatment differ between antisynthetase syndrome and systemic sclerosis
Ophir Freund, Tali Eviatar, Roni Meidan, Tamar Shalmon, Dana Stav, Tzlil Hershko, Tal Moshe Perluk, Ori Wand, Sonia Schneer, Yochai Adir, David Shitrit, Ori Elkayam, Amir Bar‐Shai, Avraham Unterman